
Sign up to save your podcasts
Or


The Veterans Health Administration announced earlier this week that it will cover Leqembi, a new Alzheimer’s drug that appears to slow the disease’s progression. Host Megan Messerly talks with Katherine Ellen Foley about why the VHA’s decision differs from other federal agencies.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By POLITICO4.7
453453 ratings
The Veterans Health Administration announced earlier this week that it will cover Leqembi, a new Alzheimer’s drug that appears to slow the disease’s progression. Host Megan Messerly talks with Katherine Ellen Foley about why the VHA’s decision differs from other federal agencies.
Learn more about your ad choices. Visit megaphone.fm/adchoices

610 Listeners

1,523 Listeners

698 Listeners

112,802 Listeners

964 Listeners

308 Listeners

56,532 Listeners

105 Listeners

499 Listeners

206 Listeners

664 Listeners

6,444 Listeners

141 Listeners

387 Listeners

40 Listeners

12 Listeners

615 Listeners